From the Sector

Parkdale Mills Collaborates with FDA, Gates Foundation and Others to Supply Swabs for Coronavirus Tests

Parkdale Mills subsidiary U.S. Cotton has joined in an effort with the Food & Drug Administration (FDA), the Gates Foundation, UnitedHealth Group and Quantigen to ramp up production of spun synthetic swabs to help the country’s frontline health care workers administering tests for the COVID-19 disease.

U.S. Cotton has developed a fully synthetic, polyester-based Q-tip-type swab that can be used in coronavirus diagnostic testing.  The U.S. Food and Drug Administration just announced that these synthetic swabs – with a design similar to Q-tips – could be used to test patients for the coronavirus.
U.S. Cotton, based in Cleveland, Ohio, plans to leverage its large-scale manufacturing capacity to rapidly increase production of large quantities of the polyester swabs, which are in short supply for testing kits across the country.

The FDA has determined that spun synthetic swabs can be used in COVID-19 testing based on the results from a clinical investigation stemming from its collaboration with UnitedHealth Group, the Gates Foundation and Quantigen.  

This is the second major COVID-19 relief project that Parkdale has helped. Earlier Parkdale constructed a supply chain that includes Hanes, Fruit of the Loom, and many other U.S. companies in the production of PPE masks needed by frontline medical staff treating the virus.

• All motions approved
• Dividend of CHF 4.50 agreed
• COVID-19

In relation to participation in the Annual General Meeting on April 16, 2020, the Board of Directors of Rieter Holding Ltd. arranged exclusively written or electronic voting and the granting of power of attorney to the independent proxy. In taking this approach, the Board of Directors relied on Article 6a, lit. b of Ordinance 2 of the Swiss Federal Council (Measures to Combat the Coronavirus of March 16, 2020). Physical participation by the shareholders was therefore not possible. The Annual General Meeting was held on the premises of Rieter Holding Ltd. at the company’s headquarters in Winterthur.

At the Annual General Meeting of Rieter Holding Ltd. on April 16, 2020, the independent proxy represented a total of 2 025 shareholders who hold 64.3% of the share capital.

A dividend of CHF 4.50 per share was agreed. The shareholders approved the proposed maximum total amounts of the remuneration of the members of the Board of Directors and of the Group Executive Committee for fiscal year 2021.

The Chairman of the Board, Bernhard Jucker, and the members of the Board of Directors This E. Schneider, Michael Pieper, Hans-Peter Schwald, Peter Spuhler, Roger Baillod, Carl Illi and Luc Tack were confirmed for an additional one-year term of office.
Furthermore, This E. Schneider, Hans-Peter Schwald and Bernhard Jucker, the members of the Remuneration Committee who were standing for election, were also each re-elected for a one-year term of office.

Shareholders also adopted all other motions proposed by the Board of Directors, namely approval of the annual report, the financial statements and the consolidated financial statements for 2019, and formal approval of the actions of the members of the Board of Directors and those of the Group Executive Committee in the year under review. In addition, the authorized capital was extended for a further two years.

COVID-19
At present, it is not possible to predict how the global COVID-19 pandemic will affect Rieter’s sales and earnings in the first and second half of 2020, and thus also for 2020 as a whole.

Rieter therefore refrains from providing an outlook for financial year 2020 and will issue the relevant information as part of the semi-annual report on July 16, 2020.
The company has taken the necessary measures to protect employees and to meet commitments to customers as far as possible.

Thanks to long-standing customer relationships, a focus on innovation, global positioning and the company’s financial stability, Rieter will successfully overcome the challenges.

Tests conducted by independent laboratories have now confirmed that a treatment with Sanitized® T 99-19 and Sanitized® T 11-15 reduces the viral load on PES textiles by up to 99 %.

Swiss company SANITIZED AG celebrates validation from impartial labs that Sanitized®T 99-19 and Sanitized®T 11-15 are also effective against viruses (in accordance with ISO 18184:2019).
Tests were performed using a feline coronavirus with structures and mechanisms reminiscent of SARS-Cov2.

Patented technology featuring an ammonium silicate compound is employed in Sanitized®T 99-19 and Sanitized®T 11-15 utilizes tried and tested silver technology. These additives are the perfect tool for an antiviral and antibacterial treatment of face masks, protective professional medical clothing, bed linens, or mattresses.
The formulation of both products remains completely untouched, thus ensuring that it will continue to offer outstanding protection against bacteria.

Before a final product’s antiviral properties can be publicly promoted, viral tests must be performed in specialized laboratories. Compliance with local legal regulations is essential here. SANITIZED AG explicitly points out that this is standard procedure and has composed a preliminary Guide for Treating PPE

SANITIZED AG has been supporting the work of hygienists in hospitals, doctor’s offices, nursing and care facilities for many years with its antimicrobial - and now also antiviral - additives used to enhance the
functionality of textiles and polymers. The reduction of bacteria and viruses is a feasible way to help stem the spread of infections including MRSA.

Elevate Textiles, a global provider of advanced, high quality products and mission critical textile solutions is pleased to participate in the recently launched Gerber PPE Task Force. This industry-wide effort combines resources and expertise to support manufacturing operations and brands as they increase their production or transition their operations to produce personal protective equipment in the fight against COVID-19.
Elevate’s Burlington, American & Efird (A&E), and Gütermann brands provide critical barrier fabric and thread components used in the manufacturing of lifesaving PPE products including masks, isolation gowns and other medical garments.

"The only way to be successful during this difficult situation is to join forces and support one another," said Lenny Marano, VP of Product Management & Marketing for Automation Systems at Gerber Technology. "We are proud to have a global network of partners to support PPE production so that it's more widely available."

For over 40 years, Burlington has been in the Medical business manufacturing fabrics for use in operating theaters such as surgeon’s gowns, isolation gowns, sterilization wrapper packs, drapes, scrubs and lab coats. The Maxima® collection of fabrics is useful for reusable isolation and surgical gowns and meets AAMI standards for Levels 1-4 and FDA standards.

The National Council of Textile Organizations (NCTO), representing the full spectrum of U.S. textiles from fiber through finished products, issued a statement from NCTO President and CEO Kim Glas today in response to the administration’s plan to institute a 90-day deferral on MFN tariffs,  as reported by numerous press outlets.

The reported plan being pushed by the importing and retailing industries would defer certain tariffs, including those on finished apparel products. It is an ill-advised policy that will hurt the U.S. textile industry at the very time it is answering the call of the nation to produce medical supplies to battle the coronavirus pandemic. 

These unnecessary tariff concessions would benefit importers and retailers at the direct expense of manufacturers on the front lines of the COVID-19 response and send a demoralizing message.

Tariff deferrals would severely exacerbate ramifications for the U.S. economy, manufacturers and workers and open the floodgates for imports.

If the U.S. government makes tariff concessions during this crisis, it will be inviting a virtual tsunami of imports further devastating domestic manufacturing as it attempts to regain its footing.     

We urge the administration to abandon any moves to defer tariffs on finished products. It would only serve to allow importers to exploit the current crisis, while dealing a severe blow to U.S. manufacturing and its workers.  

NCTO is a Washington, DC-based trade association that represents domestic textile manufacturers, including artificial and synthetic filament and fiber producers. 

• U.S. employment in the textile supply chain was 585,240 in 2019. 
• The value of shipments for U.S. textiles and apparel was $75.8 billion in 2019. 
• U.S. exports of fiber, textiles and apparel were $29.1 billion in 2019. 
• Capital expenditures for textile and apparel production totaled $2.5 billion in 2018, the last year for which data is available.

Perlon®, a Serafin Group company, is continuing to produce its’ quality filaments at all five sites for its’ customers in the current challenging climate. Production in China has been operating again as normal since the beginning of March after having to be temporarily halted due to the spreading of Covid-19. Production is now back up to 100%.

Production in Germany at our sites in Munderkingen (Baden-Wuerttemberg), Bobingen (Bavaria) and Wald-Michelbach (Hesse) as well as in the USA is continuing to run without any constraints. Therefore all sites are working to full capacity. In particular in the paper machine clothing area is showing an increase in sales which offsets a reduced demand in other areas such as automotive.

To manage the current situation responsibly, all hygiene measures at all our sites have been significantly increased so that the employees are protected as well as possible. There is hand sanitizer in every department and all of our production lines are disinfected several times a day. It has been explained to employees, what they should do in the current climate in order to minimise risk. Where possible employees are able to work from home. Perlon® has approximately 650 employees in Germany, over 80 in the USA and more than 100 in China.

High demand for monofilament for the paper industry
The paper industry is currently experiencing a rise in demand worldwide – and Perlon® is also benefitting from this, as customers need even more high quality monofilament and twisted yarns for the tensioning of paper machines. For the paper machine clothing field, Perlon® produced filaments are used to manufacture press fabric, which can be used either as a conveyor belt or for moisture removal on a paper production line. Due to the high mechanical strain through the presses, polyamide monofilaments or twisted yarns are therefore almost always used. Paper industry customers have increased their production recently. Whether it’s boxes to cope with the increased demand for online deliveries or paper for hygiene purposes (which everybody can identify with), there is an increased demand worldwide. The dental, hygiene and food preparation fields are also experiencing increased demand. To this end, Perlon® offers filaments for the manufacture of toothbrushes and high quality cleaning system brushes.

Amid the rapid spread of COVID-19 around the world, DyStar’s global operations continue to adapt to the development of the situation and to mitigate potential risks or impacts across the business. While the trajectory is unknown, DyStar is guided by recommendations from the World Health Organization and the local government authorities, to proactively address situations that could possibly affect our people and customers. This is to ensure that we have effective plans and standard procedures to minimize the disruption of our global operations.

Business Continuity Plan (BCP)
As a globally operating company, each of our operating sites, manufacturing plants, offices have a Business Continuity Plan (BCP) in place to sustain our operations and the supply chains we serve. The BCP, owned by our Business Continuity Management Team, provides clear guidance for all local operations, such as Administration, Customer Services, Finance, Logistics Services, Sales and Technical Support as well as Procurement, to enable all functions to continue operating effectively to serve our customers, distributors and agents.

Emergency Response Plan (ERP)
DyStar’s manufacturing sites are also installed with an Emergency Response Procedure to cover all emergency circumstances, including the COVID-19 pandemic disease. The goal of the emergency response procedure is to mitigate the impact of such events on people and the environment, ensuring operational readiness of the site during an emergency.

As the world adjusts to the impact of the COVID-19 pandemic, DyStar will continue to monitor the situation very closely and will provide updates that adapt to the changing situation. We remain committed to provide our customers with excellent service and to work closely with all our partners throughout this difficult period.

Brown Wrote to President Outlining Critical Steps White House can Take Now to Address Shortage of Personal Protective Equipment

 U.S. Sen. Sherrod Brown (D-OH) hosted a news conference call to discuss his plan for addressing the shortage of personal protective equipment (PPE) needed by healthcare workers on the frontline of keeping Americans healthy and safe during the coronavirus pandemic.

This weekend, Brown wrote to President Trump outlining several steps the Administration should take immediately to address the shortage and ramp up manufacturing of these critical medical supplies.

In his plan and in his letter to the President, Brown lists nine steps the Administration could take immediately, including:

1. Designate a government official who can serve as a point person responsible for coordination the acquisition and development of PPE, medical devices, and other supplies necessary to fight the coronavirus pandemic. 
2. Establish a PPE and medical device assessment and database to monitor the supply and anticipated needs for PPE, ventilators, diagnostic test kits, and other needed medical supplies to respond to the coronavirus pandemic. 
3. Publish a list of PPE, medical device, and general medical supply needs to respond to the coronavirus pandemic. 
4. Establish a hotline capable of handling significant call capacity that will provide U.S. producers centralized information about the results of the national assessment and the current need for PPE, devices, and other health care supplies. 
5. Provide immediate funding to manufacturers to purchase equipment, retool machinery, hire additional workers, and cover any other expenses needed to increase production of PPE and necessary medical devices and supplies.
6. Streamline contract and certification procedures to ensure production and delivery of materials are not delayed due to paperwork constraints.
7. Provide critical protections for workers who are making PPE, medical devices, and necessary supplies to receive a waiver from any shelter-in-place requirements to allow workers to volunteer to go to work in these critical industries. 
8. Provide purchase guarantees and delivery assistance of product to the communities and health care facilities that need the products most. 
9. Support companies that have the capacity to sterilize reusable equipment to alleviate the existing PPE shortage. 

In his plan, Brown also pointed out important legislative actions that will help ramp up production of these critical supplies, including expanding the strategic national stockpile authority, substantially increasing Defense Production Act funding and strengthening domestic preferences.

Textile innovator and specialty chemical producer Devan answers questions regarding anti-viral textile finish solutions following the growing spread of the COVID-19 outbreak.

Over the past few weeks, Devan has received a lot of questions regarding an antiviral solution for textiles against Sars-COV-2, the virus that causes COVID-19. “Not a big surprise since we put BI-OME AV forward 3 years ago. Testing has been done in cooperation with Institut Pasteur de Lille”, says Devan CEO Sven Ghyselinck. Devan studied enveloped viruses (e.g. H1N1, Corona-types, etc.) as well as naked viruses (e.g. Rotavirus). For both virus families, BI-OME AV showed strong to excellent activity in wet state.

In the first instance, the company wants to focus on professionals who need to stay working such as policemen, logistics workers, shop employees, day-care workers, … A common complication of respiratory viral disease can be a secondary bacterial infection. Professionals could be helped with either an anti-bacterial on their facemask to reduce the chance for these secondary bacterial infections, for better hygiene and less odor build-up. On workwear, a combination of a virus spread reducing and antibacterial solution could help as these garments are typically used during long hours, are non-disposable and most likely will be washed at home.

Devan has solutions which withstand washing while keeping its performance. BI-OME as a liquid product is EU BPR, Turkish BPR and US EPA registered. Depending on the rash region, commercialising treated articles be subject to additional local registration procedures.

Textile innovator and specialty chemical producer Devan answers questions regarding anti-viral textile finish solutions following the growing spread of the COVID-19 outbreak.

Devan studied enveloped viruses (e.g. H1N1, Corona-types etc.) as well as naked viruses (e.g. Rotavirus). For both virus families BI-OME AV showed strong activity in wet state.
In the first instance, the company wants to focus on professionals who need to stay working such as policemen, logistics workers, shop employees, day-care workers.

A common complication of respiratory viral disease can be a secondary bacterial infection. Professionals could be helped with either an anti-bacterial on their facemask to reduce the chance for these secondary bacterial infections, for better hygiene and less odour build-up. On workwear, a combination of a virus spread reducing and antibacterial solution could help as these garments are typically used during long hours, are non-disposable and most likely will be washed at home.